FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

24018511000001102: Xigduo 5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Mar 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
78555501000001110 Xigduo 5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
80013301000001110 Xigduo 5mg/1000mg tablets (AstraZeneca UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xigduo 5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient Dapagliflozin propanediol monohydrate true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Dapagliflozin 5mg / Metformin 1g tablets true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient Metformin hydrochloride true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient Dapagliflozin false Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Xigduo true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has active ingredient Metformin true Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient Dapagliflozin false Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient Dapagliflozin propanediol monohydrate false Inferred relationship Existential restriction modifier
Xigduo 5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dapagliflozin false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Xigduo 5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has AMP True Xigduo 5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start